Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115401) titled 'Observation on the efficacy of 0.05% cyclosporine in treating dry eye syndrome caused by thyroid-associated ophthalmopathy' on Dec. 25, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Northern Theater Command General Hospital of the Chinese People's Liberation Army
Condition:
Dry eye syndrome caused by thyroid-associated ophthalmopathy
Intervention:
CsA Group:0.05% Cyclosporine
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-06-01
Target Sample Size: CsA Group:33;control group:33;
Countries of Recruitment:
China
To know more, visit https://w...